SōRSE partners with Pascal Biosciences to begin a cannabinoid-based cancer therapy clinical trial
SōRSE Technology CEO Howard Lee tells Proactive the privately-held Seattle-based company has partnered with Canadian biotech Pascal Biosciences to …
source